Sem Sælands vei 3
Forskere har funnet ut at tida i mors mage er viktigere enn hva man tidligere har trodd.
We welcome new PharmaTox post doc Christian Page. Below he presents himself.
Read the PharmaTox yearly report to see what PharmaTox researchers achieved in 2019!
Hedvig, Sarah and Anders represented PharmaTox at the NorPEN meeting in Aarhus 14th to 15th November 2019 in Aarhus.
Hedvig Nordeng represented PharmaSafe/PharmaTox at ICPE in Philapelphia.
We welcome new PhD students Emilie Willoch Olstad and Gabriel Balaban. Below they present themselves and their background.
Guro completed her master in Molecular Biosciences with a final grade of A, 24th of June 2019.
Niloufar Mozaffari and Josephine Sena Lumor completed two PharmaTox-projects in June 2019.
Acknowledging UiO:Life Science Internationalization support
PhD student Anna S Frank spent Summer 2019 as a guest scientist at the Department of Statistics and Data Science, Cornell University, New York, USA. Read more about her visit below.
See a video abstract of the recently published systematic review on the use and validity of child neurodevelopent outcome measures in studies on prenatal exposure to psychotropic and analgesic medications.
New article by PharmaSafe researchers on the impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age.
Professor Hedvig Nordeng is one of the researchers involved in the new and massive European research project ConcePTION, where the aim is to generate the knowledge that pregnant women want – and need – about the safety of medications.
Read the travel report from PhD students Nils A. Labba and Martin Falck.
PharmaTox PhD students had several contributions to NFIF's annual conference.
Read the PharmaTox yearly report to see what PharmaTox researchers achieved in 2018.
Earlier this winter, PharmaTox arranged a winter seminar at Holmenkollen.
Read an interview with Ragnhild Eskeland about her research on Epigenetics.
PharmaTox Postdoc Mussie Ghezu Hadera have been awarded three travel grants. Congratulations!
The Pharmacovigilance Risk Assessment Committee (PRAC) is the European Medicines Agency's (EMA) committee responsible for assessing and monitoring the safety of human medicines.